Jim Cramer’s 10 Stock Picks You Need to Know

5. Intuitive Surgical Inc. (NASDAQ:ISRG)

Number of Hedge Fund Investors: 67

Jim Cramer believes that if someone is investing in robotics, Intuitive Surgical Inc. (NASDAQ:ISRG) is the best choice. He considers it the safer option in this sector. Cramer has featured Intuitive Surgical Inc. (NASDAQ:ISRG) on his show and expresses a strong positive view of the company.

“I think if you’re going to be in robotics, you have to be in ISRG. That’s the safer play. We have ISRG on the show, and I really like them.”

Baron Health Care Fund stated the following regarding Intuitive Surgical, Inc. (NASDAQ:ISRG) in its Q2 2024 investor letter:

“Intuitive Surgical, Inc. (NASDAQ:ISRG) manufactures the da Vinci Surgical System, a robotic surgical system used for minimally invasive procedures. The stock performed well due to excitement about the company’s new robotic surgical system, the da Vinci 5, which offers enhanced imaging, force feedback, and other improvements. We continue to believe Intuitive has durable competitive advantages and will remain the market leader in robotic surgery. We think the company has a long runway for growth as more procedures are performed with the company’s equipment.”

Intuitive Surgical Inc. (NASDAQ:ISRG) is an attractive investment due to its dominant role in the robotic surgery market and its strong financial results. Intuitive Surgical Inc. (NASDAQ:ISRG)’s primary product, the da Vinci Surgical System, is widely used in hospitals globally, driving steady revenue through sales of instruments, accessories, and services. In Q2 2024, Intuitive Surgical Inc. (NASDAQ:ISRG) reported earnings per share of $1.78, up from $1.18 the previous year, and revenue of $2.01 billion, marking a 14.5% increase from the same period last year.

This performance highlights Intuitive Surgical Inc. (NASDAQ:ISRG)’s ability to generate impressive returns and maintain healthy profit margins, driven by a 20% increase in surgical procedures. With analysts issuing “buy” ratings and raising price targets—such as Citigroup’s increased target of $560—there is strong confidence in Intuitive Surgical Inc. (NASDAQ:ISRG)’s future growth. The expanding use of robotic surgery in healthcare supports Intuitive Surgical Inc. (NASDAQ:ISRG)’s promising outlook. Given its leading position and strong financials, Intuitive Surgical Inc. (NASDAQ:ISRG) represents a solid long-term investment opportunity.